Dr. Schwartz's clinical interests involve inpatient and outpatient care of patients with neurovascular diseases, mostly ischemic and hemorrhagic stroke.

Dr. Shapiro's laboratory question in developmental biology involves the mechanisms used to generate the three-dimensional organization of a cell from a one-dimensional genetic code.

Dr. Schneider's laboratory study innate immunity and microbial pathogenesis.

Dr. Schatzberg's current research is in biological bases of depressive disorders, glucocorticoid/dopamine interactions in delusional depression, and pharmacologic treatment of depressive disorders.

Dr. Sapolsky's current studies are in neuron death, stress, and gene therapy.

Dr. Sarnow's laboratory has been been studying the mechanism by which a liver-specific microRNA, miR-122, regulates the amplification of the hepatitis C virus (HCV) genome in cultured cells.

Dr. Julia Salzman's lab is primarily a computational data science laboratory focused on studying RNA biology with a secondary focus on validation and novel experimental design to enable statistical analysis of RNA expression.

Dr. Santiago's research focuses on the study of microscale transport phenomena including electrokinetic flow, electrohydrodynamic instabilities, and general convective-diffusion-electromigration processes.

Dr. Sage's research program focuses on the mechanisms that control the proliferation of mammalian cells under normal and pathological conditions (regeneration, cancer), with a particular emphasis on stem cells and gene regulatory networks.

Dr. Saberi research interests include algorithms, approximation algorithms, and algorithmic aspects of games, markets, and networks.